The prognostic role of LAG-3 expression in metastatic colorectal cancer

被引：1
|
作者：
Huang, Y-H. [1 ]
Lee, C-T. [2 ]
Lin, P. C. [1 ]
Chan, R-H. [3 ]
Chen, P-C. [3 ]
Lin, B-W. [3 ]
Shen, M-R. [4 ]
Chen, S-H. [5 ]
Yeh, Y-M. [1 ]
机构：
[1] NCKUH Natl Cheng Kung Univ Hosp, Dept Oncol, Tainan, Taiwan
[2] NCKUH Natl Cheng Kung Univ Hosp, Dept Pathol, Tainan, Taiwan
[3] NCKUH Natl Cheng Kung Univ Hosp, Dept Surg, Tainan, Taiwan
[4] NCKUH Natl Cheng Kung Univ Hosp, Dept Obstet & Gynecol, Tainan, Taiwan
[5] Natl Hlth Res Inst, Natl Inst Canc Res, NIH, Tainan, Taiwan
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.249
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
114P
引用
收藏
页码：S1514 / S1515
页数：2
相关论文
共 50 条
  • [21] LAG-3: another brake to release in breast cancer?
    Kok, M.
    ANNALS OF ONCOLOGY, 2017, 28 (12) : 2907 - 2908
  • [22] Analysis of LAG-3 expression in metastatic melanoma patients treated with combination anti-LAG-3+anti-PD-1-based immunotherapies
    Gide, T. N.
    Paver, E.
    Yaseen, Z.
    Menzies, A. M.
    Wilmott, J. S.
    Scolyer, R. A.
    Long, G. V.
    HISTOPATHOLOGY, 2022, 81 : 54 - 54
  • [23] The correlation between LAG-3 expression and the efficacy of chemoimmunotherapy in advanced biliary tract cancer
    Tang, Cheng-Yu
    Lin, Yi-Ting
    Yeh, Yi-Chen
    Chung, Shin-Yi
    Chang, Yu-Chan
    Hung, Yi-Ping
    Chen, San-Chi
    Chen, Ming-Huang
    Chiang, Nai-Jung
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2025, 74 (02)
  • [24] MET expression and prognostic effect in metastatic colorectal cancer (mCRC)
    Kennecke, H.
    Schaeffer, D. E.
    Yin, Y.
    Tai, I. T.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S565 - S565
  • [25] Prognostic role of β-catenin and p53 expression in the metastatic progression of sporadic colorectal cancer
    Pancione, Massimo
    Forte, Nicola
    Fucci, Alessandra
    Sabatino, Lina
    Febbraro, Antonio
    Di Blasi, Arturo
    Daniele, Bruno
    Parente, Domenico
    Colantuoni, Vittorio
    HUMAN PATHOLOGY, 2010, 41 (06) : 867 - 876
  • [26] LAG-3 antagonists by cancer treatment: a patent review
    Perez-Santos, Martin
    Anaya-Ruiz, Maricruz
    Cebada, Jorge
    Bandala, Cindy
    Landeta, Gerardo
    Martinez-Morales, Patricia
    Villa-Ruano, Nemesio
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2019, 29 (08) : 643 - 651
  • [27] LAG-3: recent developments in combinational therapies in cancer
    Chavanton, Aude
    Mialhe, Flavie
    Abrey, Jimena
    Garcia, Alvaro Baeza
    Garrido, Carmen
    CANCER SCIENCE, 2024, 115 (08) : 2494 - 2505
  • [28] Expression and Prognostic Significance of LAG-3, TIGIT, VISTA, and IDO1 in Endometrial Serous Carcinoma
    Chen, Hao
    Molberg, Kyle
    Carrick, Kelley
    Niu, Shuang
    Colon, Glorimar Rivera
    Gwin, Katja
    Lewis, Cheryl
    Lea, Jayanthi
    Panwar, Vandana
    Zheng, Wenxin
    Castrillon, Diego H.
    Lucas, Elena
    MODERN PATHOLOGY, 2024, 37 (08)
  • [29] LAG-3 in Non-Small-cell Lung Cancer: Expression in Primary Tumors and Metastatic Lymph Nodes Is Associated With Improved Survival
    Hald, Sigurd M.
    Rakaee, Mehrdad
    Martinez, Inigo
    Richardsen, Elin
    Al-Saad, Samer
    Paulsen, Erna-Elise
    Blix, Egil Store
    Kilvaer, Thomas
    Andersen, Sigve
    Busund, Lill-Tove
    Bremnes, Roy M.
    Donnem, Tom
    CLINICAL LUNG CANCER, 2018, 19 (03) : 249 - +
  • [30] The expression of PD-1 and LAG-3 in periapical lesions
    Wang, Hai-Sheng
    Yang, Fu-Hua
    Li, Yuan
    Pei, Fei
    Kulkarni, Ashok B.
    Chen, Zhi
    Zhang, Lu
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2018, 10 (08): : 2677 - 2684
12345